An Observational Study of Tarceva (Erlotinib) in Routine Daily Clinical Practice as Second Line Treatment in Patients With Non-small Cell Lung Cancer

Clinical trial NCT01161173 · COMPLETED

Trial details

NCT number: NCT01161173
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Study type: OBSERVATIONAL

Nonsquamous Nonsmall Cell Neoplasm of Lung

Start date: 2008-04-01
Primary completion: 2012-08-01
Enrollment: 347

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.